Gregory Cary, Ph.D.

Bioinformatics Analyst III

Prioritizing candidate drug targets for diseases with complex etiologies

My research has focused on the logic of gene expression regulation, particularly in response to stress. In particular, I have utilized and integrated high-dimensional data to address complex questions about regeneration, neurodegeneration, development, and evolution. My role in the Open-AD consortium is to integrate genomic evidence in support of the prioritization and development of new therapeutic targets for the treatment of Alzheimer's disease.

Gregory Cary on ORCID

          Download CV         

Education and experience


Carnegie Mellon University
Postdoctoral fellow
Adv: Dr. Veronica Hinman

University of Washington
Ph.D., Molecular and Cellular Biology
Adv: Aimee Dudley

Colby College
B.A., Biology